IL10 and COVID-19: The elevation of pro-inflammatory cytokines and IL-10, an anti-inflammatory cytokine, unveils the dual dynamics of the immune response in the pathogenesis of COVID-19, suggesting the need for therapeutic strategies that effectively modulate this response.